---
category: news
title: "A2 Bio to Present at ASCO-GI 2022 on Use of Next Generation Sequencing (NGS) to Identify GI Cancer Patients for Future Tmod™ CAR T Therapy"
excerpt: "Press Release A2 Biotherapeutics, Inc. (\"A2 Bio\") is a biotechnology company focused on the development of a first-in-class, logic-gated Tmod™ CAR T cell therapy platform to tackle the fundamental challenge in solid tumor treatment-the ability of cancer"
publishedDateTime: 2022-01-19T05:25:00Z
originalUrl: "https://venturebeat.com/2022/01/18/a2-bio-to-present-at-asco-gi-2022-on-use-of-next-generation-sequencing-ngs-to-identify-gi-cancer-patients-for-future-tmod-car-t-therapy/"
webUrl: "https://venturebeat.com/2022/01/18/a2-bio-to-present-at-asco-gi-2022-on-use-of-next-generation-sequencing-ngs-to-identify-gi-cancer-patients-for-future-tmod-car-t-therapy/"
ampWebUrl: "https://venturebeat.com/2022/01/18/a2-bio-to-present-at-asco-gi-2022-on-use-of-next-generation-sequencing-ngs-to-identify-gi-cancer-patients-for-future-tmod-car-t-therapy/amp/"
cdnAmpWebUrl: "https://venturebeat-com.cdn.ampproject.org/c/s/venturebeat.com/2022/01/18/a2-bio-to-present-at-asco-gi-2022-on-use-of-next-generation-sequencing-ngs-to-identify-gi-cancer-patients-for-future-tmod-car-t-therapy/amp/"
type: article

provider:
  name: VentureBeat
  domain: venturebeat.com
  images:
    - url: "https://everyday-cc.github.io/ai/assets/images/organizations/venturebeat.com-50x50.jpg"
      width: 50
      height: 50

topics:
  - AI in Healthcare
  - AI

secured: "+JMEQ/KxnVMgvt7WDaimcELUpts4CPsaao2aHOCfrzM0gq09rtHjzdtLoDIPW+Vv5ouUlLsD4NtowkJWG2hfu92eFHRXttj6oDmWDRpVXKefKzDy5b1ixJpSl0viWr6dEdfk3oiasG/ekaslKJrvytPa65TZHIlkvs5rwv5oeKOUhglXZRs9H+2jdaiXX2E+jBIV/KnVE9H0QoJuRgQRKoLkWLv/P7t37So67mFPkQL2o+iH0ZUPcwljp03A9SUSvr79V3Vkb8K/QGwnK6uaunBUjCe3qqMdhShGat6MQypvEDlqrNi1vDJSbIXD1loxR9G6ZGRqEAWurVY2K6WSKKMVAwKYUO2tNHBxVCaKi+M=;ES7qDqj2v4g/egKUdw7Hng=="
---

